Second Generation Technologies Driving Commercial Opportunities

By Ken Rubenstein, Ph.D.

Published: April, 2003

220+ Pages, 15+ Exhibits, 29 Companies Profiled 

Microfluidic product revenues are forecasted to grow by more than 50% per year through 2007.  D&MD's Microfluidics Market Analysis Report thoroughly analyzes the evolution of commercial microfluidics with emphasis on the forces driving recent shifts in company strategies and approaches to the market. These strategy shifts have presented a wide array of application areas, which are described in depth, including relevant predictions for future revenue potential. In addition, this report discusses the current focuses on business aspects of microfluidics, including the competitive environment, business models employed by market participants, and a thorough market analysis with revenue estimates and projections for the field as a whole and the most commercially viable segments. 

This Report Will Help You:

> Predict and react to growth areas with discussion of key market drivers for specific application areas with projected revenues and growth rates through 2007

> Understand the current commercial environment with in-depth discussions of how companies are shifting focus and strategies to meet market needs

> Remain current on emerging microfluidic technologies via a thorough examination and assessment of technologies underlying new products and applications

> Gain reliable market insight from analysis of why and how microfluidics and microfluidic companies will need to evolve in order to sustain growth over the long term

> Assess commercial application and funding opportunities presented by the biowarfare defense sector

> Keep your eye on the primary companies involved in microfluidics with extensive profiles of their technologies, business strategies, partnering activities, and more 

Featuring Analysis of These Application Areas:

> Processing for Microarrays or Mass Spectrometry

> Patch Clamping Chips with Ion Channel Targets

> Cell Processing Units for High Content Screening

> Target Amplification for Nucleic Acid Assays

And more...

Publisher: Drug and Market Development 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a95